Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
Twitter Feed
-
Already prioritising the sessions through the #ASBMR2019 meeting App! I think I need to clone myself for the meet the expert session! Perhaps @asbmr could record the sessions for later viewing? #UCBtakeover
— UCB News (@ucb_news) 19.09.2019 -
Hello everyone! @JavaidKassim here and looking forward to bringing you all my experiences of #ASBMR2019 this weekend! What are you most looking forward to seeing? #UCBtakeover https://t.co/BopTIad4oI
— UCB News (@ucb_news) 19.09.2019 -
Find out why #diversity & #inclusion matter to UCB. https://t.co/U4zp1p27wV https://t.co/VHOAEsMw8M
— UCB News (@ucb_news) 19.09.2019
